Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
Abbi L. Engel, Gregory E. Holt, Hailing Lu
Expert Review of Clinical Pharmacology (2011) Vol. 4, Iss. 2, pp. 275-289
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 3, pp. 175-196
Open Access | Times Cited: 2112
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell, Sean P. Arlauckas, Michael F. Cuccarese, et al.
Nature Biomedical Engineering (2018) Vol. 2, Iss. 8, pp. 578-588
Open Access | Times Cited: 884
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay Kumar
International Immunopharmacology (2018) Vol. 59, pp. 391-412
Open Access | Times Cited: 571
Inflammation and the two-hit hypothesis of schizophrenia
Keith Feigenson, Alex Kusnecov, Steven M. Silverstein
Neuroscience & Biobehavioral Reviews (2013) Vol. 38, pp. 72-93
Open Access | Times Cited: 261
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer
Fumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
JCI Insight (2017) Vol. 2, Iss. 18
Open Access | Times Cited: 248
Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications
Yueh-Hsia Luo, Louis W. Chang, Pinpin Lin
BioMed Research International (2015) Vol. 2015, pp. 1-12
Open Access | Times Cited: 226
Immune system targeting by biodegradable nanoparticles for cancer vaccines
Joana M. Silva, Mafalda Videira, Rogério Gaspar, et al.
Journal of Controlled Release (2013) Vol. 168, Iss. 2, pp. 179-199
Closed Access | Times Cited: 226
Vaccine adjuvant uses of poly-IC and derivatives
Karen Martins, Sina Bavari, Andres Μ. Salazar
Expert Review of Vaccines (2014) Vol. 14, Iss. 3, pp. 447-459
Closed Access | Times Cited: 204
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Alessio Facciolà, Giuseppa Visalli, A. Laganà, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 819-819
Open Access | Times Cited: 160
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
Sachin Bhagchandani, Jeremiah A. Johnson, Darrell J. Irvine
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113803-113803
Open Access | Times Cited: 124
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines
Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo
Molecular Pharmaceutics (2021) Vol. 18, Iss. 8, pp. 2867-2888
Open Access | Times Cited: 107
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
Lana E. Kandalaft, Denarda Dangaj, George Coukos
Nature reviews. Cancer (2022) Vol. 22, Iss. 11, pp. 640-656
Closed Access | Times Cited: 100
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
T. R. Chen, Mingzhao Wang, Yanchao Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 29
Clinical landscape of macrophage-reprogramming cancer immunotherapies
Jenna H. Rannikko, Maija Hollmén
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 627-640
Open Access | Times Cited: 16
The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management
Kiarash Saleki, Parsa Alijanizadeh, Nima Javanmehr, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 3, pp. 1267-1325
Open Access | Times Cited: 15
TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages
Zhipeng Liu, Yue Xie, Yao Xiong, et al.
Cancer Letters (2019) Vol. 469, pp. 173-185
Closed Access | Times Cited: 135
Potentiating Cancer Immunotherapy Using Papaya Mosaic Virus-Derived Nanoparticles
Marie‐Ève Lebel, Karine Chartrand, Esther Tarrab, et al.
Nano Letters (2016) Vol. 16, Iss. 3, pp. 1826-1832
Open Access | Times Cited: 123
Lymph node-targeted immune-activation mediated by imiquimod-loaded mesoporous polydopamine based-nanocarriers
Lu Wang, Ye He, Tingting He, et al.
Biomaterials (2020) Vol. 255, pp. 120208-120208
Closed Access | Times Cited: 87
FcγR engagement reprograms neutrophils into antigen cross-presenting cells that elicit acquired anti-tumor immunity
Vijayashree Mysore, Xavier Culleré, Joseph Mears, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 83
Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy
Christopher B. Rodell, Maaz S. Ahmed, Christopher Garris, et al.
Theranostics (2019) Vol. 9, Iss. 26, pp. 8426-8436
Open Access | Times Cited: 77
Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
Jia Zhuang, Maya Holay, Joon Ho Park, et al.
Theranostics (2019) Vol. 9, Iss. 25, pp. 7826-7848
Open Access | Times Cited: 76
Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications
Abdul Samad Basheer, Faridah Abas, Iekhsan Othman, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4226-4226
Open Access | Times Cited: 73
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 61
Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy
DaeYong Lee, Kristin Huntoon, Yifan Wang, et al.
Advanced Materials (2021) Vol. 33, Iss. 27
Closed Access | Times Cited: 58
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
Judith Stickdorn, Lara Stein, Danielle Arnold-Schild, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 4426-4443
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top